{
    "code": "06024002",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06024002",
    "time": "2020-02-25 20:37:26",
    "許可證字號": "衛署醫器輸字第024002號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD4464",
    "有效日期": "111\/09\/04",
    "發證日期": "101\/09\/04",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "通關簽審文件編號": "DHA00602400209",
    "中文品名": "亞培高風險人類乳突瘤病毒檢驗試劑套組",
    "英文品名": "Abbott RealTime High Risk HPV",
    "效能": "亞培高風險人類乳突瘤病毒檢驗試劑套組為一體外定性檢驗方法，可以偵測臨床檢體中是否存在高風險人類乳突瘤病毒的DNA(包括14種基因亞型：16、18、31、33、35、39、45、51、52、56、58、59、66和68)。\r\n新增效能（規格：02N09-092）：詳如中文仿單核定本。",
    "醫器規格": "2N09-80 Abbott RealTime High Risk HPV Control Kit, 2N09-90 Abbott RealTime High Risk HPV Amplification Reagent Kit,以下空白。\r\n新增規格：02N09-092。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器次類別一": "C0004人類乳突瘤病毒血清試劑",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "0932301100  美商亞培股份有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "主製造廠": [
        {
            "製造廠名稱": "MDE0201000  ABBOTT GMBH &amp; CO.KG",
            "製造廠廠址": "MAX-PLANCK-RING 2,65205 WIESBADEN,GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "20171117152640632-106-11-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06024002&Seq=004&Type=9"
        },
        {
            "title": "20171117152640632-106-11-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06024002&Seq=005&Type=8"
        }
    ]
}